This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
Performance driven by growth portfolio momentum, pipeline advancements, and strategic business development
The antibody was designed and developed at Abzena’s Cambridge, UK,
The company's net income attributable to equity holders dropped to €2.80 billion from €2.82 billion last year
Takeda will make an upfront payment of $1.2 billion, which includes a $100 million equity investment in Innovent
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
Approval broadens indication for Tezspire to a second disease characterized by epithelial-driven inflammation
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
